Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology

Aim. To reveal latent disorders of carbohydrate metabolism (CHM) in conjunction with neurohormonal status in hospitalized patients with chronic heart failure (CHF) of ischemic etiology.Material and methods. We analyzed 174 patients with NYHA class II-IV CHF of ischemic etiology who received the same...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Noruzbaeva, B. T. Kurmanbekova, G. E. Osmankulova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2019-04-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/776
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698942317494272
author A. M. Noruzbaeva
B. T. Kurmanbekova
G. E. Osmankulova
author_facet A. M. Noruzbaeva
B. T. Kurmanbekova
G. E. Osmankulova
author_sort A. M. Noruzbaeva
collection DOAJ
description Aim. To reveal latent disorders of carbohydrate metabolism (CHM) in conjunction with neurohormonal status in hospitalized patients with chronic heart failure (CHF) of ischemic etiology.Material and methods. We analyzed 174 patients with NYHA class II-IV CHF of ischemic etiology who received the same standard CHF therapy (P-adrenergic blockers, mineralocorticoid receptor antagonists, angiotensin-converting enzyme inhibitors, diuretics), did not have disorders of CHM and never took hypoglycemic agent. We conducted oral glucose tolerance test (OGTT) and general clinical examination. The levels of brain natriuretic peptide, aldosterone and insulin was determined by enzyme immunoassay. Insulin resistance (IR) is assessed using the HOMA-IR index.Results. Among 174 hospitalized patients with NYHA class II-IV CHF of ischemic etiology disorders of CHM was detected in 52,3% of patients: 33,9% of those had impaired glucose tolerance (IGT), 1,7% — impaired fasting glucose (IFG), 16,7% — newly diagnosed type 2 diabetes mellitus (DM), in 47,7% of the patients disorders of CHM was not found. In all patients with CHF, along with elevated levels of brain natriuretic peptide and aldosterone, insulin levels were also increased. IR elevated with the increase in the severity of disorders of CHM (in the group without disorders of CHM — 10,78 (8,9-12,2), IGT — 14,6 (11,2-18,2), newly diagnosed type 2 DM — 18,6 (15,19-26,7). Also the concentration of aldosterone was higher in the group with DM, compared with the ITG group (p2-3<0,01).Conclusion. The presence and progression of IR in patients with CHF of ischemic etiology in conjunction with neurohormonal status emphasizes the importance of timely detection of latent CHM disorders with its future management.
format Article
id doaj-art-d925239678a34c4d8e2198c84e0e4bac
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 2019-04-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-d925239678a34c4d8e2198c84e0e4bac2025-08-20T03:18:45Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252019-04-01182263110.15829/1728-8800-2019-2-26-311916Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiologyA. M. Noruzbaeva0B. T. Kurmanbekova1G. E. Osmankulova2National Center for Cardiology and Therapy named after Academician M. MirrakhimovNational Center for Cardiology and Therapy named after Academician M. MirrakhimovNational Center for Cardiology and Therapy named after Academician M. MirrakhimovAim. To reveal latent disorders of carbohydrate metabolism (CHM) in conjunction with neurohormonal status in hospitalized patients with chronic heart failure (CHF) of ischemic etiology.Material and methods. We analyzed 174 patients with NYHA class II-IV CHF of ischemic etiology who received the same standard CHF therapy (P-adrenergic blockers, mineralocorticoid receptor antagonists, angiotensin-converting enzyme inhibitors, diuretics), did not have disorders of CHM and never took hypoglycemic agent. We conducted oral glucose tolerance test (OGTT) and general clinical examination. The levels of brain natriuretic peptide, aldosterone and insulin was determined by enzyme immunoassay. Insulin resistance (IR) is assessed using the HOMA-IR index.Results. Among 174 hospitalized patients with NYHA class II-IV CHF of ischemic etiology disorders of CHM was detected in 52,3% of patients: 33,9% of those had impaired glucose tolerance (IGT), 1,7% — impaired fasting glucose (IFG), 16,7% — newly diagnosed type 2 diabetes mellitus (DM), in 47,7% of the patients disorders of CHM was not found. In all patients with CHF, along with elevated levels of brain natriuretic peptide and aldosterone, insulin levels were also increased. IR elevated with the increase in the severity of disorders of CHM (in the group without disorders of CHM — 10,78 (8,9-12,2), IGT — 14,6 (11,2-18,2), newly diagnosed type 2 DM — 18,6 (15,19-26,7). Also the concentration of aldosterone was higher in the group with DM, compared with the ITG group (p2-3<0,01).Conclusion. The presence and progression of IR in patients with CHF of ischemic etiology in conjunction with neurohormonal status emphasizes the importance of timely detection of latent CHM disorders with its future management.https://cardiovascular.elpub.ru/jour/article/view/776chronic heart failureinsulin resistanceprediabetestype 2 diabetescoronary artery disease
spellingShingle A. M. Noruzbaeva
B. T. Kurmanbekova
G. E. Osmankulova
Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
Кардиоваскулярная терапия и профилактика
chronic heart failure
insulin resistance
prediabetes
type 2 diabetes
coronary artery disease
title Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
title_full Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
title_fullStr Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
title_full_unstemmed Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
title_short Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
title_sort identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
topic chronic heart failure
insulin resistance
prediabetes
type 2 diabetes
coronary artery disease
url https://cardiovascular.elpub.ru/jour/article/view/776
work_keys_str_mv AT amnoruzbaeva identificationoflatentdisordersofcarbohydratemetabolisminconjunctionwithneurohormonalstatusinhospitalizedpatientswithchronicheartfailureofischemicetiology
AT btkurmanbekova identificationoflatentdisordersofcarbohydratemetabolisminconjunctionwithneurohormonalstatusinhospitalizedpatientswithchronicheartfailureofischemicetiology
AT geosmankulova identificationoflatentdisordersofcarbohydratemetabolisminconjunctionwithneurohormonalstatusinhospitalizedpatientswithchronicheartfailureofischemicetiology